Carl-Wilhelm Vogel

Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model

Siao‐Yi Wang, Suresh Veeramani, Emilian Racila et al. · Blood · 2009 · 135 citations · Full text

Life Sciences, Hematology, Immunology +16

Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells

Sydney Welt, E A Carswell, Carl-Wilhelm Vogel et al. · Clinical Immunology and Immunopathology · 1987 · 59 citations

Life Sciences, Immunology, Oncology +17

Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside

Héctor A. Cabrera-Fuentes, Corina Alba-Alba, Julián Aragonés et al. · Basic Research in Cardiology · 2015 · 36 citations · Full text

Medicine, Cardiology, Molecular Medicine +16

Structure of the major oligosaccharide of cobra venom factor

D. Channe Gowda, Michael Schultz, Reinhard Bredehorst et al. · Molecular Immunology · 1992 · 31 citations

Life Sciences, Biochemistry, Biology +14